Join the fight and help us discover the genetic basis of ALS. Start or support a local initiative to raise funds. Project MinE, make it yours!
100 percent of all donations to Project Mine will go directly towards the mapping and analysis of DNA profiles.
In France the Project MinE research is conducted at the University Hospital of Tours and the University Hospital of Limoges. The ALS centers of these hospitals are major referral centers for ALS patients in France. The dedicated teams provide multidisciplinary care for ALS patients and caregivers and are also engaged in clinical research. Research projects include studies in ALS genetics and clinical trials. The centers are committed to international collaborations to speed up the search for a cure of ALS and are therefore participating in Project MinE.
Project MinE research in France is performed at Université François-Rabelais, Tours and at Université de Limoges
Professor Philippe Corcia is an expert in motor neuron diseases (MNDs). He is Neurologist in the University Hospital of Tours since 1995 and member of the ARSLA Scientific Board and of the Team 2 “Génétique et Métabolomique” of the Inserm Unit UMR U930,”Imagerie et Cerveau” Tours.
Since 2012 he is investigator in STRENGTH (Survival, Trigger and Risk, Epigenetic, eNvironmental and Genetic Targets for motor neuron Health), NUTRALS (Impact d’une supplémentation alimentaire précoce par voie orale sur l’état fonctionnel des patients atteints de sclérose latérale amyotrophique) and PULSE (PHRC: Etude des facteurs prédictifs de l’évolutivité de la sclérose latérale amyotrophique. Caractéristiques pronostiques et endophénotypiques. Mise en place d’une banque nationale de données). He is coordinator of the MARIA project (Microglial Activation Role In ALS) and the project “Evaluation of the glutamate-induced alterations of the metabolism in an in vitro model of ALS using metabolomics and transcriptomics approaches” a project is financially supported by the ARSLA association.
Professor Philippe Couratier is an expert in motor neuron diseases (MNDs). He is Neurologist in the University Hospital of Limoges since 1991. He is head of the Neurology Department and “Pôle Neurosciences Tête Cou et Os” of CHU Limoges, chairman of the Groupe Français d’Etude des Maladies du Motoneurone GFEMM and the Scientific Board for the “Association pour la Recherche sur la SLA (ARSla), coordinator of the ALS Centre CHU Limoges and member EURALS (Consortium for the European Research on Epidemiology of ALS), the French Network on FTD/ALS, and the French Neurological Society (SFN).
He is (co)investigator in several European Research Projects, such as Project MinE, TRICALS and SOPHIA, PULSE (PHRC; ‘Etude des facteurs prédictifs de l’évolutivité de la sclérose latérale amyotrophique’ Caractéristiques pronostiques et endophénotypiques. Mise en place d’une banque nationale de données’), and PREV-DEMALS (ANR; Predict to prevent frontotemporal lobar degeneration and amyotrophic lateral sclerosis), in therapeutic clinical trials (Cytokinetics, NogoA, Respistim). He is coordinator of Sub-Head: epidemiology of ALS UMR 1094 University of Limoges, BMAALS (ANR; First study in France searching a link between Amyotrophic Lateral Sclerosis and BMAA’s cyanotoxin) and NUTRALS (Impact d’une supplémentation alimentaire précoce par voie orale sur l’état fonctionnel des patients atteints de sclérose latérale amyotrophique).
In France fundraising for Project MinE is led by ARSLA
